Drug spin-off trend gains traction with IPO by Hengrui offshoot
A company set up to develop Hengrui Pharma’s weight-loss drugs has made a strong debut on the U.S. equity market, building confidence in the “NewCo” business model Key Takeaways: Hengrui’s…
Recent Articles
Drug spin-off trend gains traction with IPO by Hengrui offshoot
1276.HK
600276.SHG
